Differential Diagnosis of Hyperleukocytosis

Malignant Causes

The American Society of Hematology recommends distinguishing between malignant and reactive causes of hyperleukocytosis, with acute leukemias being the most life-threatening etiologies requiring immediate intervention 1, 2
Acute Myeloid Leukemia (AML) carries a higher early mortality rate (23% vs 5% in ALL) due to intracerebral hemorrhage and pulmonary leukostasis, particularly in monocytic/myelomonocytic subtypes (FAB M4/M5) 3

Severe bacterial infections can produce WBC counts >50,000/μL but rarely exceed 100,000/μL, and must be considered in the differential diagnosis 4
Sepsis with leukemoid reaction can cause marked leukocytosis, but rarely exceeds 100,000/μL 4

The presence of blasts (>20% in peripheral blood or bone marrow) is indicative of acute leukemia 1
Cell morphology, such as monocytic features (M4/M5 AML), indicates a higher risk for leukostasis 3
Associated cytopenias, such as anemia and thrombocytopenia, suggest malignancy over reactive process 4
Clinical presentation, including leukostasis symptoms (pulmonary infiltrates, altered mental status, retinal hemorrhages), indicates an acute leukemia emergency 1, 2

Complete blood count with differential should be evaluated for all cell lines for cytopenias 4
Peripheral blood smear review is mandatory for blast morphology 4
Bone marrow aspiration and biopsy should be obtained immediately if acute leukemia is suspected 4
Coagulation studies should be performed to detect DIC, particularly in APL 6, 7

Hydration and cytoreduction should not be delayed while awaiting definitive diagnosis if hyperleukocytosis is present, as early death from complications can occur before diagnosis is confirmed 4
Leukapheresis should not be performed in APL without excluding this diagnosis first, as it can cause fatal hemorrhage 4
Red blood cell transfusions should not be excessive until WBC is reduced, as this can increase blood viscosity and worsen leukostasis 1, 2